 |
ID#: GFIN-1036 |
Nutraceutical Product Manufacturer
|
PROJECTED REVENUE:
  $20,000,000 |
PROJECTED EBITDA:
$10,650,000 |
LOCATION:
Midwest Region |
| $20,000,000,000. + |
| Chattem, Johnson & Johnson, Performance Health Inc., Novartis Consumer Health Inc., CCA Industries, Mission Pharmacal, DRJ Group, G.H.C. Group, NFI Consumer Products, Alcis, Inc |
|
|
Proven Track Record
Profitable
Multiple Products
Established Distribution
Outsourced Manufacturing
Cash Cow
Great Potential |
1. Most Advanced Formula
2. Affordable
3. Repeat Customers
4. Steady Growth
|
|
|
| This would be the perfect company to acquire as an 'add on' if you are already in this space. If you have an interest in diversifying into this $20.0 + Billion Industry, this would be the perfect 'platform' acquisition from which to further expand. If you have a successful 'premium product' that is heavily advertised, eliminate your competition by placing this product next to it, and offer both. If you don't, someone else will, and they will reap the benefit. It's already happening now. |
Proven Nutraceutical, Topical Pain Relieving product with a 16 year track record, already listed in major retailers, showing growth of 28% last year with no advertising, is your foot in the door for the complete line, as well as other products you may already have. |
|
| Extremely High Development and Marketing Costs and then it's a gamble whether or not the product sells. Competitors spend millions of dollars before they even know if the product is going to be successful. This product is already there with a success story. |
|
|
Established product that's been in a major retail chain for over 15 years running! Just having the spot on the shelf is extremely valuable. The retailer has just recently moved them up to a better position on the shelf because sales have been so strong. All this has been done with virtually no advertising dollars spent. |
|
| |
|
Eagleaf Disclaimer: This site makes no representations, and specifically disclaims all warranties, express, implied or statutory, regarding the accuracy, timeliness, completeness, merchantability, or fitness for any particular purpose of any material contained on this site. Eagleaf does not warrant that the information on our Website will be accurate, complete, uninterrupted or error-free, or that defects will be corrected. The information contained herein does not suggest or imply and should not be construed, in any manner, a guarantee of future performance and / or investment advice. There is no implied or expressed warranties on the information and materials in this site. The information and materials are provided "as is". Eagleaf and its employees specifically disclaim any liability, loss, or risk, personal or otherwise, incurred directly or indirectly as a consequence of the use and application of any information on this Website. Use of this service is at your own risk.
